Impact of insurance status on overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

OBJECTIVES: The impact of insurance status on oncological outcome in patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is poorly understood. METHODS: Retrospective study on 31 patients having undergone 36 CRS-HIPEC at a single institution (safety-net hospita...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pleura Peritoneum
Hlavní autoři: Chokshi, Ravi J., Kim, Jin K., Patel, Jimmy, Oliver, Joseph B., Mahmoud, Omar
Médium: Artigo
Jazyk:Inglês
Vydáno: De Gruyter 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7746885/
https://ncbi.nlm.nih.gov/pubmed/33364338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/pp-2020-0105
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky